Brouwers Melissa C, Chambers Alexandra, Perry James
Program in Evidence-based Care, Cancer Care Ontario, Hamilton, Ontario, Canada.
BMC Health Serv Res. 2003 Dec 19;3(1):23. doi: 10.1186/1472-6963-3-23.
Clinical practice guidelines are systematically developed statements designed to assist in patient and physician clinical decision making for specific clinical circumstances. In order to establish which guideline topics are priorities, practitioners were surveyed regarding their current practice.
One hundred ninety-seven practitioners in Ontario, Canada were mailed a survey exploring their current practice or opinion regarding the prophylactic use of anticonvulsant drugs in patients with malignant glioma who had never had a seizure. The survey consisted of seven questions regarding the relevance of a guideline on the subject to the practitioner's practice, the proportion of clinical cases involving anticonvulsant use, knowledge of existing guidelines on this topic, interest in reviewing a completed practice guideline and three clinical scenarios.
There were 122 respondents who returned the survey (62% rate of return). Eighty percent of the practitioners who responded indicated that less than 25% of their clinical cases involved the use of anticonvulsants; however, only 16% of respondents indicated that a practice guideline would be irrelevant to their practice. Eighty percent of respondents volunteered to review a draft version of a practice guideline on the use of anticonvulsants. The survey presented the practitioners with three scenarios where anticonvulsants in patients with brain tumours may be appropriate: peri-operatively in patients without seizures, postoperatively in patients currently using anticonvulsants, and thirdly in patients not currently using anticonvulsants or undergoing surgery. In contrast to the third situation, the first two situations yielded considerable variation in practitioner response.
The survey established that there is some variation present in the current practice of anticonvulsant use in the patients with brain tumours. Whether there is an optimal treatment practice has yet to be determined. Practitioners do seem to feel that a guideline on anticonvulsant use in warranted, and most practitioners would be interested in being part of the guideline development process.
临床实践指南是系统制定的声明,旨在协助患者和医生针对特定临床情况做出临床决策。为了确定哪些指南主题是优先事项,对从业者的当前实践进行了调查。
向加拿大安大略省的197名从业者邮寄了一份调查问卷,以探究他们对从未发生过癫痫的恶性胶质瘤患者预防性使用抗惊厥药物的当前实践或看法。该调查问卷包括七个问题,涉及该主题指南与从业者实践的相关性、涉及使用抗惊厥药物的临床病例比例、对该主题现有指南的了解、对审查完整实践指南的兴趣以及三个临床场景。
有122名受访者回复了调查问卷(回复率为62%)。回复的从业者中有80%表示其临床病例中使用抗惊厥药物的比例不到25%;然而,只有16%的受访者表示实践指南与他们的实践无关。80%的受访者自愿审查抗惊厥药物使用实践指南的草案版本。该调查问卷向从业者呈现了三种情况,即脑肿瘤患者使用抗惊厥药物可能是合适的:在未发生癫痫的患者围手术期、在目前正在使用抗惊厥药物的患者术后,以及在目前未使用抗惊厥药物或未接受手术的患者中。与第三种情况不同,前两种情况在从业者的回答中产生了相当大的差异。
该调查表明,目前脑肿瘤患者抗惊厥药物使用的实践存在一些差异。是否存在最佳治疗实践尚待确定。从业者似乎确实认为有必要制定抗惊厥药物使用指南,并且大多数从业者有兴趣参与指南的制定过程。